Callan Family Office’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
Callan Family Office's ACLS Position: Q2 2026 in Review
Callan Family Office increased its Axcelis (ACLS) stake by 0.78% in Q2 2026, buying an estimated $2.97K and bringing the position to 2,568 shares worth $487K. The position accounts for 0.01% of the portfolio, ranked #828.
Callan Family Office first reported a position in ACLS in Q4 2025 and has held it in 3 quarters since. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Callan Family Office held 2,568 shares of Axcelis worth $487K as of Q2 2026.
- Callan Family Office bought 20 Axcelis shares in Q2 2026, an estimated $2.97K.
- Axcelis made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #828 holding.
- Callan Family Office first reported a position in Axcelis in Q4 2025 and has held it in 3 quarters since.
- 443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.